SBFM: Sunshine Biopharma, Inc. Stock

by  •  • Comments Off on SBFM: Sunshine Biopharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 0.89
Enterprise Value ($M) -15.40
Book Value ($M) 21.21
Book Value / Share 21.32
Price / Book 0.04
NCAV ($M) 18.75
NCAV / Share 18.85
Price / NCAV 0.05

Profitability (mra)
Return on Invested Capital (ROIC) -0.21
Return on Assets (ROA) -0.17
Return on Equity (ROE) -0.23

Liquidity (mrq)
Quick Ratio 3.45
Current Ratio 4.48

Balance Sheet (mrq) ($M)
Current Assets 24.89
Assets 27.35
Liabilities 6.14
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 24.09
Operating Income -4.79
Net Income -4.51
Earnings Per Share Policy Basic n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -8.78
Cash from Investing -0.66
Cash from Financing 3.43

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-23 13G L1 Capital Global Opportunities Master Fund, Ltd. 5.30
02-21 13G Altium Capital Management LP 9.99
02-14 13G Armistice Capital, Llc 7.60

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2023 ☐ TRANSITION REPORT PURSUAN
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-16 732,988 2,465,896 29.73
2024-05-15 698,894 2,122,440 32.93
2024-05-14 2,908,369 1,172,875 247.97
2024-05-13 388,918 1,646,614 23.62

(click for more detail)

Similar Companies
RZLT – Rezolute, Inc. SABS – SAB Biotherapeutics, Inc.
SAVA – Cassava Sciences, Inc. SCLX – Scilex Holding Company
SEEL – Seelos Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io